Avadel Pharmaceuticals

NASDAQ: AVDL · Real-Time Price · USD
13.69
0.19 (1.41%)
At close: Aug 15, 2025, 3:59 PM
13.64
-0.33%
After-hours: Aug 15, 2025, 07:44 PM EDT

Avadel Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-26.41M -48.83M -72.58M -106.22M -156.83M -160.28M -158.94M -142.81M -141.82M -137.46M -132.31M -134.17M -90.31M -77.33M -66.31M -56.01M -5.55M
Depreciation & Amortization
2.96M 2.68M 2M 1.55M 1.72M 1.77M 2.37M 2.18M 1.82M 1.49M 1.11M 904K 856K 815K 1.01M 1.13M 1.45M
Stock-Based Compensation
19.18M 20.39M 19.78M 17.5M 19.68M 15.81M 14.22M 13.02M 6.03M 7.01M 7.87M 8.31M 9.65M 8.87M 7.38M 5.22M 3.98M
Other Working Capital
46.37M 43.13M 41.78M 16.69M 15.66M 15M 5.42M 20.02M 9.52M 11.99M 11.93M -934K 6.61M 7.42M 6.18M 6.1M -4.85M
Other Non-Cash Items
-28.25M -18.16M -839.66K 27.09M 28.21M 19.99M 4.89M 7.16M 8.98M 8.09M 6.13M 4.52M 2.49M 2.3M -12K -1.07M -46.96M
Deferred Income Tax
n/a n/a -15.94M -15.94M -2.81M -2.81M 13.24M 13.28M 30.35M 26.02M 21.57M 16.43M -17.45M -15.67M -14.17M -13.82M -1.52M
Change in Working Capital
15.98M 8.41M -4.42M -27.32M -7.14M -3M 8.38M 22.75M 28.15M 24.54M 18.19M 12.13M 6.83M 3.69M -1.83M 1.66M -11.91M
Operating Cash Flow
-25.43M -46.91M -82.81M -114.14M -127.98M -128.51M -115.85M -84.42M -66.49M -70.3M -77.44M -91.88M -87.94M -77.31M -73.93M -62.88M -60.51M
Capital Expenditures
3.05 3.05 3.05 n/a n/a n/a -716K -1.43M -1.43M -1.43M -715.56K 869.35 857.13 -25.14K -90.58K -124.01K -124K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a -3.24M -3.24M -3.24M -3.24M n/a n/a n/a 8.25M 11M 11M
Purchase of Investments
-183.81M -276M -295.67M -298.96M -324.68M -237.23M -204.6M -114.67M -11.55M -3.41M -5.51M -10.6M -26.09M -61.77M -65.74M -86.9M -167.61M
Sales Maturities Of Investments
226.52M 327.78M 360.47M 368.52M 290.91M 187.14M 149.45M 52.95M 54.78M 83.83M 78.37M 92.51M 105.83M 102.22M 89.94M 86.78M 62.23M
Other Investing Acitivies
-3.05 21.39M 21.39M 31.21M -61.7M -78.02M -77.31M -83.89M 21.07M 58.26M 57.26M 53.75M 49.95M 15.95M 23.53M 26.56M 32.81M
Investing Cash Flow
42.71M 51.78M 64.8M 69.56M -33.77M -50.09M -55.15M -62.44M 42.51M 79.7M 72.14M 81.91M 87.99M 56.93M 48.85M 27.26M -71.76M
Debt Repayment
n/a n/a -21.16M -21.16M -21.16M -38.66M -17.5M -17.5M -17.5M n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -16K -16K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.47M 6.72M 5.89M 35.17M -8.15M -12.07M -20.28M -50.56M -12.76M -10.78M -2.87M -2.94M 1.86M n/a -1.74M -1.86M -1.43M
Financial Cash Flow
3.47M 15.97M -6.02M 23.26M 114.08M 135.34M 163.07M 143.32M 46.98M 14.54M 8.18M -2.42M 2.39M 526.07K 446.07K 316.07K 117.62M
Net Cash Flow
15.58M 20.2M -23.23M -21.14M -47.6M -42.81M -8.9M -4.14M 22.52M 23.27M 2.55M -13.01M 1.7M -21.01M -24.94M -35.03M -14.33M
Free Cash Flow
-25.43M -46.91M -82.81M -114.14M -127.98M -128.51M -116.56M -85.86M -67.92M -71.74M -78.16M -91.88M -87.94M -77.34M -74.02M -63.01M -60.63M